TARA logo

TARA
Protara Therapeutics Inc

5,515
Mkt Cap
$276.37M
Volume
300,119.00
52W High
$7.82
52W Low
$2.77
PE Ratio
-3.82
TARA Fundamentals
Price
$5.03
Prev Close
$5.11
Open
$5.16
50D MA
$6.03
Beta
1.22
Avg. Volume
969,595.73
EPS (Annual)
-$1.34
P/B
1.39
Rev/Employee
$0.00
$76.12
Loading...
Loading...
News
all
press releases
Jacqueline Zummo Sells 22,598 Shares of Protara Therapeutics (NASDAQ:TARA) Stock
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) insider Jacqueline Zummo sold 22,598 shares of Protara Therapeutics stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $5.26, for a total value of $118,865.48. Following the completion of the sale...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Insider Selling: Protara Therapeutics (NASDAQ:TARA) Insider Sells 22,598 Shares of Stock
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) insider Jacqueline Zummo sold 22,598 shares of the business's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $5.26, for a total transaction of $118,865.48. Following the transaction, the...
MarketBeat·4d ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat reports...
MarketBeat·6d ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Sees Large Increase in Short Interest
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) was the target of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...
MarketBeat·8d ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Short Interest Up 48.0% in February
Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) saw a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 4,895,488 shares, an...
MarketBeat·23d ago
News Placeholder
FY2030 Earnings Forecast for TARA Issued By HC Wainwright
Protara Therapeutics, Inc. (NASDAQ:TARA - Free Report) - Stock analysts at HC Wainwright issued their FY2030 earnings per share estimates for shares of Protara Therapeutics in a research note issued...
MarketBeat·25d ago
News Placeholder
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Protara Therapeutics, Inc. (NASDAQ:TARA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are currently covering the firm...
MarketBeat·1mo ago
News Placeholder
Protara Therapeutics (NASDAQ:TARA) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on shares of Protara Therapeutics in a report on Wednesday. They issued an "overweight" rating and a $27.00 target price for the company...
MarketBeat·1mo ago
News Placeholder
Protara Therapeutics Highlights TARA-002 NMIBC Data, FDA Plans for Lymphatic Malformations at Oppenheimer Conf
Protara Therapeutics (NASDAQ:TARA) executives outlined progress across the company's two clinical-stage programs during a fireside chat at Oppenheimer's 36th Annual Healthcare Life Sciences...
MarketBeat·1mo ago
News Placeholder
Protara Therapeutics (TARA) to Release Earnings on Wednesday
Protara Therapeutics (NASDAQ:TARA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 4. (View Earnings Report at...
MarketBeat·1mo ago
<
1
2
...
>

Latest TARA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.